Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-29

Clinical Trial Update: CRx-102 Osteoarthritis Multicenter Evaluation Trial [Phase 2]

View source ↗

Summary

Phase 2 multicenter trial of CRx-102 for knee Osteoarthritis was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CRx-102

Snippet

Sponsor: Zalicus | Conditions: Knee Osteoarthritis | Phase 2 | Status: TERMINATED | Results posted: 2014-04-29